UroGen refinances debt with Pharmakon at 8.25% fixed rate Mar 2, 2026 07:55AM
UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors Mar 2, 2026 07:55AM
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference Feb 24, 2026 04:05PM
Form SCHEDULE 13G/A UroGen Pharma Ltd. Filed by: Cowen Financial Products LLC Nov 14, 2025 11:27AM
TD Cowen on UroGen Pharma (URGN): 'The Early Launch Is Ramping Nicely & 2026 Should Inflect' Aug 14, 2025 11:01AM


Jul 29, 2025 04:56PM Form SCHEDULE 13G/A UroGen Pharma Ltd. Filed by: Cowen Financial Products LLC
Jun 13, 2025 11:38AM Form SCHEDULE 13G UroGen Pharma Ltd. Filed by: Cowen Financial Products LLC
May 27, 2025 04:00PM UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA
Feb 24, 2025 04:00PM UroGen Pharma to Present at TD Cowen 45th Annual Health Care Conference
Nov 14, 2024 08:37AM Form SC 13G/A UroGen Pharma Ltd. Filed by: COWEN AND COMPANY, LLC
Aug 13, 2024 02:10PM TD Cowen Reiterates Buy Rating on UroGen Pharma (URGN)
Jul 23, 2024 09:19AM TD Cowen Reiterates Buy Rating on UroGen Pharma (URGN)
Jun 24, 2024 05:25PM Form SC 13G UroGen Pharma Ltd. Filed by: COWEN AND COMPANY, LLC
Jun 17, 2024 10:51PM UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
Jun 17, 2024 04:47PM UroGen Pharma (URGN) Commences Share and Warrant Offering
Jun 17, 2024 04:46PM UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
Jun 13, 2024 02:21PM TD Cowen Reiterates Buy Rating on UroGen Pharma (URGN)
May 22, 2024 08:00AM UroGen Pharma to Present at the TD Cowen 5th Annual Oncology Innovation Summit
Feb 26, 2024 08:00AM UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference
Dec 5, 2023 08:35AM UroGen Pharma (URGN) Named Best Idea for 2024 at TD Cowen
Mar 1, 2023 04:00PM UroGen Pharma to Present at Upcoming Investor Conferences
Mar 8, 2022 08:00AM UroGen Secures $100 Million Non-Dilutive Term Loan Financing with Pharmakon Advisors Allowing Funding to Cash Flow Breakeven
Feb 28, 2022 08:00AM UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference
Mar 18, 2021 07:30AM UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
Feb 23, 2021 08:00AM UroGen Pharma Announces March 2021 Conference Schedule
Feb 25, 2020 08:00AM UroGen Pharma Announces March 2020 Investor Conference Schedule
Mar 5, 2019 08:00AM UroGen Pharma to Present at March 2019 Investor Conferences
Mar 7, 2018 08:00AM UroGen to Present at March 2018 Investor Conferences
Mar 7, 2018 08:00AM UroGen to Present at March 2018 Investor Conferences
Jan 23, 2018 04:01PM UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option
Jan 23, 2018 04:01PM UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option
Jan 19, 2018 05:56AM UroGen Pharma (URGN) Prices 1.46M Shares at $41
Jan 18, 2018 07:10PM UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
Jan 18, 2018 07:10PM UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
Jan 16, 2018 04:05PM UroGen Pharma (URGN) Announces Proposed Public Offering of Ordinary Shares
Jan 16, 2018 04:05PM UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
Jan 16, 2018 04:05PM UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
May 30, 2017 05:43AM Cowen Starts UroGen Pharma (URGN) at Outperform
May 10, 2017 08:00AM UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 4, 2017 05:59AM UroGen Pharma (URGN) Prices 4.473M Share IPO at $13/Sh
May 3, 2017 05:55PM UroGen Pharma Announces Pricing of Initial Public Offering